This is the authors' abstract. We don't add key points for this paper.
Objectives Given the complications from cancer treatment affecting children, adolescents and young adults, it is essential to establish individualized and progressive survivorship care plans (SCPs). Implementing current evidence-based guidelines into clinical practice can contribute to a personalised approach. To support this person-centered care, a digital tool was developed through a participatory approach in the GOCE network (Western region Childhood Cancer in France) and distributed to other comprehensive French cancer centers (LOG-after). This INCa-funded THINK-project aimed to compare the SCPs generated by LOG-after with those proposed by oncologists, pediatric oncologists and radiation oncologists. Study design A questionnaire comprising 3 clinical cases (acute lymphoblastic leukemia, Hodgkin's lymphoma, nephroblastoma) was circulated among 3 national networks (SFCE, AYA group, Pediatric radiotherapy). Responses were compared with SCPs generated by LOG-after, and attitudes were discussed in workshops. Results Thirty-six practitioners participated, including 5 radiation oncologists. Thirteen respondents considered themselves experts in survivorship care. SCP varied significantly between practitioners with no complete agreement. However, there was greater alignment between the software and practitioners for high-grade recommendations, particularly among experts (e.g., 100% of experts recommended post-anthracycline cardiac monitoring). Conclusion Given the observed heterogeneity, the LOG-after tool, which integrates the latest recommendations, is expected to improve SCP by enhancing consistency and reducing unnecessary screenings. During the workshops, participants considered the algorithm to be generally aligned with published guidelines, confirming its potential to facilitate their broader dissemination. This digital tool can help standardize evidence-based survivorship care, and potentially increase consistency in monitoring and potentially lead to better long-term health outcomes for cancer survivors
No takes yet. Share an insight, caveat, or question.
Bertrand et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: